Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-08

Clinical Trial Update: RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial is evaluating olanzapine to prevent chemotherapy-induced nausea and vomiting in children receiving highly emetogenic chemotherapy; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zyprexa (olanzapine)
  • olanzapine (olanzapine)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Vomiting in Infants and/or Children, Nausea | Phase 2 | Status: RECRUITING